SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Interim trading statement

3 Aug 2017 07:00

RNS Number : 9666M
Ebiquity PLC
03 August 2017
 

Ebiquity Plc

("the Company")

 

 

Interim trading statement

 

 

Ebiquity plc, the leading independent marketing analytics specialists, today announces its trading statement for the 6 months ended 30 June 2017 ("the period").

 

Ebiquity's total revenues have grown by 5% over the period, with operating profit and earnings anticipated to be in line with market expectations.

 

During the period we continued to deliver against the milestones set out within our Growth Acceleration Plan. As planned, we organically expanded our Marketing Effectiveness practice into Europe and Asian markets, recruited dedicated business development staff in selected markets, and invested into internal support functions.

 

Additionally we launched the Ebiquity "Media Transparency Score" to help advertisers understand how well their business operations perform in achieving the level of media transparency they desire from their marketing activities, and "Total View Attribution" which enables clients to improve the return on investment of their media, by enabling them to understand which media channels and campaigns (both online and offline in combination) are the most effective and warrant increased investment.

 

Revenues from the Media Value Measurement ("MVM") practice achieved high single digit growth, benefitting from strong performance from our Contract Compliance business as clients are more focused on achieving media transparency. However, the performance of our US MVM business was softer than anticipated during the period, due to a lower rate of client renewals. We are in the process of strengthening our US team in response to these changing client demands.

 

The Market Intelligence ("MI") practice revenues from our platform business (Portfolio), which accounts for over 90% of MI revenue, increased over the period. We launched our Portfolio Digital service in Asia Pacific and Europe, which combined with high renewal rates, has driven a return to revenue growth. As expected, revenue from our project based reputation business declined in the first half.

 

Within the Marketing Performance Optimization ("MPO") practice our Marketing Effectiveness revenues continued to grow, most notably from our UK business. Additionally, during the first half of the year in line with our Growth Acceleration Plan we recruited Marketing Effectiveness practice leaders in Germany, France and Singapore. Performance from our US based Multi-Channel Analytics practice fell behind expectations due to organisational changes at some of our largest clients.

 

Whilst the first half of the year has been softer in the US, we anticipate stronger performance from the US MPO and MVM in the second half of the year and we are pleased that the MI practice has returned to growth following high renewal rates and new product launches. Management anticipate that full year trading will be broadly in line with market expectations.

 

The Company will release its interim report for the 6 months ended 30 June 2017 on 26 September 2017.

3 August 2017

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Andrew Noble (CFO)

 

020 7650 9600

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

 

Numis Securities Limited

Nick Westlake (NOMAD)

Toby Adcock (Corporate Broker)

 

020 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGGRMZFGNZZ
Date   Source Headline
25th Jun 20187:15 amRNSStatement re CMA Phase 2 referral
15th Jun 20187:00 amRNSPartnership with Snapchat to enhance measurement
13th Jun 20187:05 amRNSStatement re CMA review of disposal
1st Jun 20189:15 amRNSTotal Voting Rights
18th May 201812:20 pmRNSHolding(s) in Company
9th May 201812:11 pmRNSAGM Resolutions Passed
9th May 20187:00 amRNSIssue of Shares
1st May 20181:10 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSDirector/PDMR Shareholding
13th Apr 20187:00 amRNSAnnual Report
12th Apr 20182:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:05 pmRNSHolding(s) in Company
21st Mar 20183:00 pmRNSDividend Declaration
21st Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSTotal Voting Rights
27th Feb 20187:00 amRNSDirectorate Change
19th Feb 20187:00 amRNSIssue of Shares
13th Feb 20182:00 pmRNSDirector/PDMR dealing and grant of options
13th Feb 20187:00 amRNS£26m disposal and pre-close trading statement
2nd Jan 20184:45 pmRNSTotal Voting Rights
19th Dec 20177:00 amRNSDirectorate Change
28th Nov 201710:15 amRNSHolding(s) in Company
17th Nov 201712:01 pmRNSIssue of Shares
8th Nov 20173:00 pmRNSIssue of Shares
26th Sep 20177:00 amRNSInterim Results
19th Sep 20175:50 pmRNSHolding(s) in Company
31st Aug 20172:45 pmRNSTotal Voting Rights
24th Aug 20177:00 amRNSIssue of Shares
21st Aug 20177:00 amRNSIssue of Shares
17th Aug 20178:52 amRNSIssue of Shares
8th Aug 20177:00 amRNSExercise of Share Options and dealing by PDMR
3rd Aug 20177:00 amRNSInterim trading statement
11th Jul 20177:00 amRNSEbiquity Launches Total View Attribution service
4th Jul 20177:00 amRNSEbiquity Launches Media Transparency Score tool
31st May 20171:00 pmRNSTotal Voting Rights
11th May 20175:05 pmRNSExercise of Share Options
10th May 201711:16 amRNSResult of AGM
2nd May 201711:05 amRNSDirector/PDMR Shareholding
21st Apr 20173:00 pmRNSAwards extension
20th Apr 20177:00 amRNSEbiquity launches 'Portfolio Digital' in the UK
18th Apr 201710:05 amRNSAnnual Report
29th Mar 201711:02 amRNSDividend Declaration
28th Mar 20177:00 amRNSFinal Results
10th Mar 20173:30 pmRNSHolding(s) in Company
26th Jan 20177:00 amRNSPre-close trading statement
2nd Dec 201612:15 pmRNSDeferred Consideration/Issue of Ordinary Shares
11th Nov 20162:48 pmRNSHolding(s) in Company
14th Oct 201612:30 pmRNSRe Directorate
6th Oct 20167:00 amRNSLaunch of Strategic Media Consultancy service
28th Sep 20167:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.